SMHX vs. QNTM
SMHX (VanEck Fabless Semiconductor ETF) is Semiconductors fund tracking the MarketVector™ US Listed Fabless Semiconductor Index, while QNTM (Quantum BioPharma Ltd) is a stock. Over the past year, SMHX returned 139.42% vs -68.42% for QNTM. At a 0.16 correlation, their price movements are largely independent.
Performance
SMHX vs. QNTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMHX achieves a 78.44% return, which is significantly higher than QNTM's -33.15% return.
SMHX
- 1D
- 0.94%
- 1M
- 33.64%
- YTD
- 78.44%
- 6M
- 72.62%
- 1Y
- 139.42%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
QNTM
- 1D
- -4.50%
- 1M
- -6.15%
- YTD
- -33.15%
- 6M
- -51.15%
- 1Y
- -68.42%
- 3Y*
- -60.52%
- 5Y*
- -47.60%
- 10Y*
- —
SMHX vs. QNTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
SMHX VanEck Fabless Semiconductor ETF | 78.44% | 30.00% | 17.76% |
QNTM Quantum BioPharma Ltd | -33.15% | 98.37% | -24.44% |
Correlation
The correlation between SMHX and QNTM is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2024 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMHX vs. QNTM — Risk / Return Rank
SMHX
QNTM
SMHX vs. QNTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Fabless Semiconductor ETF (SMHX) and Quantum BioPharma Ltd (QNTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMHX | QNTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.73 | ||
| Sortino ratioReturn per unit of downside risk | +4.45 | ||
| Omega ratioGain probability vs. loss probability | 1.59 | 1.01 | +0.59 |
| Calmar ratioReturn relative to maximum drawdown | 8.22 | -0.73 | +8.95 |
| Martin ratioReturn relative to average drawdown | 23.13 | -0.98 | +24.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SMHX | QNTM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.30 | -0.43 | +4.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.36 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.94 | -0.35 | +2.30 |
Drawdowns
SMHX vs. QNTM - Drawdown Comparison
The maximum SMHX drawdown since its inception was -38.53%, smaller than the maximum QNTM drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for SMHX and QNTM.
Loading charts...
Drawdown Indicators
| SMHX | QNTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.53% | -99.98% | +61.45% |
Max Drawdown (1Y)Largest decline over 1 year | -17.06% | -94.00% | +76.94% |
Max Drawdown (3Y)Largest decline over 3 years | — | -97.98% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -98.42% | — |
Current DrawdownCurrent decline from peak | 0.00% | -99.95% | +99.95% |
Average DrawdownAverage peak-to-trough decline | -7.33% | -92.23% | +84.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.05% | 69.94% | -63.89% |
Volatility
SMHX vs. QNTM - Volatility Comparison
The current volatility for VanEck Fabless Semiconductor ETF (SMHX) is 11.81%, while Quantum BioPharma Ltd (QNTM) has a volatility of 54.41%. This indicates that SMHX experiences smaller price fluctuations and is considered to be less risky than QNTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMHX | QNTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.81% | 54.41% | -42.60% |
Volatility (6M)Calculated over the trailing 6-month period | 25.06% | 112.88% | -87.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.69% | 159.83% | -127.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.97% | 134.07% | -94.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.97% | 140.70% | -100.73% |
Dividends
SMHX vs. QNTM - Dividend Comparison
SMHX's dividend yield for the trailing twelve months is around 0.01%, while QNTM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% |
SMHX VanEck Fabless Semiconductor ETF | 0.01% | 0.02% | 0.04% |
Frequently Asked Questions
SMHX and QNTM have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (54.41%) compared to SMHX (11.81%). In terms of maximum drawdown, SMHX dropped -38.53% vs QNTM's -99.98%.
SMHX currently has the higher Sharpe Ratio (4.30 vs -0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMHX and QNTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer